Clinical Trial Update: A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AS1411 with cytarabine for primary refractory or relapsed acute myeloid leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AS1411
• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Antisoma Research | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED